期刊文献+

脑梗死血清MMP-3的测定及临床意义 被引量:6

The Detection of Serum MMP-3 in Cerebral Infarction
下载PDF
导出
摘要 目的 :观察脑梗死患者血清基质金属蛋白酶 3(MMP 3)的含量变化 ,探讨其在脑梗死发生发展过程中的作用和意义。方法 :用ELISA法检测 5 9例脑梗死患者发病 2 4h、5d、15d ,以及 32例健康体检者血清MMP 3的含量作对照。结果 :脑梗死发病 2 4h~ 5d的血清MMP 3水平显著高于对照组 (P <0 0 5 )。脑梗死组发病初期 (2 4h~ 5d)患者血清MMP 3水平明显增高 ,随脑梗死发病时间的延长 ,血清MMP 3水平逐渐降低 ,与对照组比较无显著差异(P >0 0 5 )。脑梗死发病 2 4h~ 5d的血清MMP 3水平与神经功能缺损程度评分 (脑卒中分值 )、空腹血糖、总胆固醇、三酰甘油均无明显相关性 (P >0 0 5 )。结论 :MMP 3在脑梗死发病早期过程中起着重要的作用 ,而且血清MMP 3水平的高低与临床病程有关。 Objective: To investigate the role and clinical significance of serum MMP-3 in cerebral infarction. Methods: Serum MMP-3 levels were measured in 59 cerebral infarction patients (during 24 h~15 days of the onset) and 32 healthy people by ELISA. Results: The level of MMP-3 during 24 h~5 days of the cerebral infarction is higher than those of control ( P < 0 05). No obvious relationship were observed between the levels of MMP-3 and the fast blood sugar (FBS),total serum cholesterol,and serum glycerol. Conclusion : MMP-3 may contribute the pathologic course in the early stage of cerebral infarction,and the level of MM P-3 is correlated with the clinical course of the disease.
出处 《江苏大学学报(医学版)》 CAS 2004年第30期208-209,219,共3页 Journal of Jiangsu University:Medicine Edition
关键词 脑梗死 基质金属蛋白酶 Cerebral infarction Matrix metalloproteinase
  • 相关文献

参考文献9

二级参考文献30

  • 1Lee MH, Dodds P, Verma V, et al. Tailoring tissue inhibitor of metallopmteinases (TIMP) - 3 to overcome the weakening effects of the cysteine - rich domains of tumor necrosis factor - a converting enzyme(TACE). Biochem J, 2003, Pt[epub ahead of print].
  • 2Lee MH, Knauper V, Becherer JD, et al. Full - length and N - TIMP-3 display equal inhibitory activities toward TNF - alpha convertase. Biochem Biophys Res Commun, 2001, 280(3): 945 -950.
  • 3Hashimoto G, Aoki T, Nakamura H, et al. Inhibition of ADAMTS4(aggrecanase- 1) by tissue inhibitors of metalloproteinases (TIMP- 1,2, 3 and 4). FEBS Lett, 2001, 494(3): 192-195.
  • 4Loechel F, Fox JW, Murphy G, et al. ADAM 12 - S cleaves 1GFBP -3 and IGFBP- 5 and is inhibited by TIMP- 3. Biochem Biophys Res Commun, 2000, 278(3): 511- 515.
  • 5Rosenberg GA, Cunningham LA, Wallace J, et al. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP- 9 linked to stromelysin - 1 and microglia in cell cultures. Brain Res, 2001, 893(1-2): 104-112.
  • 6Rosenberg GA, Sullivan N, Esiri MM. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke,2001, (5): 1162-1168.
  • 7Bond M, Murphy G, Bennett MR, et al. Tissue inhibitor of metalloproteinase - 3 induces a Fas - associated death domain -dependent type Ⅱ apoptotic pathway. J Biol Chem, 2002, 277( 16):13787- 13795.
  • 8Yu WH, Yu S, Meng Q, et al. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem, 2000, 275(40) : 31236- 31232.
  • 9Fabunmi RP, Sukhova GK, Sugiyama S, et al. Expression of tissue inhibitor of metallopmteinases - 3 in human atheroma and regulation in lesion- associated cells: a potential protective mechanism in plaque stability. Circ Res, 1998, 83(3): 270-278.
  • 10Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissuesculture assay. Proc Natl Acad Sci USA, 1962, 54: 1197.

共引文献62

同被引文献50

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部